Brinker Capital Investments’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.9M | Buy |
124,118
+1,051
| +0.9% | +$121K | 0.13% | 140 |
|
|
2025
Q4 | $13M | Buy |
123,067
+8,082
| +7% | +$759K | 0.1% | 190 |
|
|
2025
Q3 | $9.65M | Sell |
114,985
-11,830
| -9% | -$974K | 0.07% | 240 |
|
|
2025
Q2 | $10M | Buy |
126,815
+876
| +0.7% | +$69.6K | 0.09% | 218 |
|
|
2025
Q1 | $11.3M | Sell |
125,939
-38,941
| -24% | -$3.64M | 0.11% | 167 |
|
|
2024
Q4 | $16.4M | Sell |
164,880
-2,515
| -2% | -$259K | 0.16% | 117 |
|
|
2024
Q3 | $19M | Sell |
167,395
-4,711
| -3% | -$560K | 0.19% | 108 |
|
|
2024
Q2 | $21.3M | Sell |
172,106
-1,315
| -0.8% | -$169K | 0.23% | 88 |
|
|
2024
Q1 | $22.9M | Sell |
173,421
-1,205
| -0.7% | -$149K | 0.25% | 79 |
|
|
2023
Q4 | $20.5M | Sell |
174,626
-13,125
| -7% | -$1.36M | 0.24% | 85 |
|
|
2023
Q3 | $19.3M | Sell |
187,751
-74,092
| -28% | -$7.99M | 0.23% | 90 |
|
|
2023
Q2 | $30.2M | Sell |
261,843
-8,875
| -3% | -$1.01M | 0.32% | 56 |
|
|
2023
Q1 | $28.8M | Buy |
270,718
+30,484
| +13% | +$3.29M | 0.36% | 47 |
|
|
2022
Q4 | $26.7M | Sell |
240,234
-1,475
| -0.6% | -$151K | 0.53% | 31 |
|
|
2022
Q3 | $20.8M | Sell |
241,709
-5,323
| -2% | -$475K | 0.43% | 40 |
|
|
2022
Q2 | $22.5M | Sell |
247,032
-20,577
| -8% | -$1.82M | 0.43% | 40 |
|
|
2022
Q1 | $22M | Buy |
267,609
+3,626
| +1% | +$286K | 0.34% | 55 |
|
|
2021
Q4 | $20.2M | Sell |
263,983
-12,282
| -4% | -$978K | 0.29% | 71 |
|
|
2021
Q3 | $21.5M | Sell |
276,265
-1,058
| -0.4% | -$80.5K | 0.34% | 67 |
|
|
2021
Q2 | $21.6M | Buy |
277,323
+71,995
| +35% | +$5.36M | 0.29% | 84 |
|
|
2021
Q1 | $15.1M | Buy |
205,328
+47,745
| +30% | +$3.52M | 0.23% | 108 |
|
|
2020
Q4 | $12.3M | Sell |
157,583
-62,790
| -28% | -$4.8M | 0.19% | 109 |
|
|
2020
Q3 | $17.5M | Buy |
220,373
+214,492
| +3,647% | +$16.8M | 0.3% | 74 |
|
|
2020
Q2 | $434K | Buy |
+5,881
| New | +$443K | 0.02% | 257 |
|
|
2020
Q1 | – | Sell |
-942
| Closed | -$82K | – | 581 |
|
|
2019
Q4 | $82K | Buy |
942
+106
| +13% | +$8.71K | ﹤0.01% | 381 |
|
|
2019
Q3 | $67K | Buy |
836
+174
| +26% | +$13.9K | ﹤0.01% | 400 |
|
|
2019
Q2 | $53K | Buy |
662
+162
| +32% | +$12.4K | ﹤0.01% | 593 |
|
|
2019
Q1 | $40K | Sell |
500
-393
| -44% | -$29.4K | ﹤0.01% | 494 |
|
|
2018
Q4 | $65K | Hold |
893
| – | – | ﹤0.01% | 372 |
|
|
2018
Q3 | $60K | Buy |
893
+172
| +24% | +$11K | ﹤0.01% | 357 |
|
|
2018
Q2 | $42K | Buy |
721
+487
| +208% | +$27.5K | ﹤0.01% | 382 |
|
|
2018
Q1 | $12K | Hold |
234
| – | – | ﹤0.01% | 450 |
|
|
2017
Q4 | $13K | Sell |
234
-52
| -18% | -$2.88K | ﹤0.01% | 424 |
|
|
2017
Q3 | $17K | Buy |
286
+52
| +22% | +$3.15K | ﹤0.01% | 409 |
|
|
2017
Q2 | $14K | Hold |
234
| – | – | ﹤0.01% | 384 |
|
|
2017
Q1 | $14K | Hold |
234
| – | – | ﹤0.01% | 378 |
|
|
2016
Q4 | $13K | Hold |
234
| – | – | ﹤0.01% | 381 |
|
|
2016
Q3 | $14K | Buy |
+234
| New | +$13.7K | ﹤0.01% | 362 |
|
|
2016
Q1 | – | Sell |
-44
| Closed | -$2K | – | 590 |
|
|
2015
Q4 | $2K | Buy |
+44
| New | +$2.22K | ﹤0.01% | 467 |
|
|
2015
Q2 | – | Sell |
-394
| Closed | -$22K | – | 437 |
|
|
2015
Q1 | $22K | Buy |
+394
| New | +$22.3K | ﹤0.01% | 339 |
|
|
2014
Q2 | – | Sell |
-419
| Closed | -$23K | – | 393 |
|
|
2014
Q1 | $23K | Buy |
419
+391
| +1,396% | +$20.2K | ﹤0.01% | 317 |
|
|
2013
Q4 | $1K | Buy |
+28
| New | +$1.28K | ﹤0.01% | 377 |
|
Other funds holding MRK
VCM
VPM
Brinker Capital Investments's MRK Position: Q1 2026 in Review
Brinker Capital Investments increased its Merck (MRK) stake by 0.85% in Q1 2026, buying an estimated $121K and bringing the position to 124,118 shares worth $14.9M. The position accounts for 0.13% of the portfolio, ranked #140.
Brinker Capital Investments first reported a position in MRK in Q4 2013 and has held it in 42 quarters since. The position peaked at $30.2M in Q2 2023. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Brinker Capital Investments held 124,118 shares of Merck worth $14.9M as of Q1 2026.
- Brinker Capital Investments bought 1,051 Merck shares in Q1 2026, an estimated $121K.
- Merck made up 0.13% of Brinker Capital Investments's portfolio in Q1 2026, its #140 holding.
- Brinker Capital Investments first reported a position in Merck in Q4 2013 and has held it in 42 quarters since.
- Brinker Capital Investments's Merck position peaked at $30.2M in Q2 2023.
- 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Brinker Capital Investments's 13F filing for Q1 2026, filed 13 May 2026.